English Türkçe
Register Sign in

Hereditary Angioedema

Hereditary Angioedema

ŞEVKET ARSLAN, FATİH ÇÖLKESEN, FİLİZ SADİ AYKAN

  •  Year : 2022
  •  Vol : 2
  •  No : 1
  •  Page : 27-37
ÖZ

ABSTRACT

It is crucial to distinguish bradikinin-mediated angioedema from mast cell-mediated angioedema. Bradykinin mediated angioedema often presents with severe or even life-threatening swelling. Bradykinin-mediated angioedema does not respond to standard treatments used for mast cell-mediated angioedema. Nowadays, the development of new drugs has made it possible to treat bradykinin-mediated angioedema-related attacks and to prevent morbidity and mortality. In this article, the known and unknown aspects of bradykinin-related angioedema, its pathophysiology, diagnosis and differential diagnosis, and treatment modalities are discussed.

Key words: Bradykinin-mediated angioedema, Hereditary angioedema
Correspondence Address :
Email : [email protected]
Cite this Article As : Sadi Aykan F, Çölkesen F, Arslan Ş. Herediter Anjioödem. Mev Med Sci. 2022;2(1):27-37

Description : Yazarların hiçbiri, bu makalede bahsedilen herhangi bir ürün, aygıt veya ilaç ile ilgili maddi çıkar ilişkisine sahip değildir. Araştırma, herhangi bir dış organizasyon tarafından desteklenmedi.Yazarlar çalışmanın birincil verilerine tam erişim izni vermek ve derginin talep ettiği takdirde verileri incelemesine izin vermeyi kabul etmektedirler. None of the authors, any product mentioned in this article, does not have a material interest in the device or drug. Research, not supported by any external organization. grant full access to the primary data and, if requested by the magazine they agree to allow the examination of data.
Hereditary Angioedema, Derleme,
, Vol. 2 (1)
Received :31.12.2021, Accepted : 22.03.2022, Published Online : 12.04.2022
Mevlana Medical Sciences Journal
ISSN: 2757-976X ;
E-ISSN: 2757-976X ;